Finance

Beta
Lists
CPIX:NASDAQ
Cumberland Pharmaceuticals, Inc.
$5.80
-0.68%
(-0.040) 1D
$5.80
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CPIX...
Open
$5.79
High
$5.88
Low
$5.56
Mkt. cap
86.90M
Avg. vol.
1.98M
Volume
62.17K
52-wk high
$6.61
52-wk low
$1.85
EPS
-$0.50
Beta
0.09
Shares outstanding
14.98M
No. of employees
93
Open
$5.79
High
$5.88
Low
$5.56
Mkt. cap
86.90M
Avg. vol.
1.98M
Volume
62.17K
52-wk high
$6.61
52-wk low
$1.85
EPS
-$0.50
Beta
0.09
Shares outstanding
14.98M
No. of employees
93
News stories
From sources across the web
About Cumberland Pharmaceuticals, Inc.
CEO-
Employees93
Founded1999
HeadquartersNashville, Tennessee, United States
SectorPharmaceutical industry
Websitecumberlandpharma.com
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.13 / -
0.00%miss
Revenue / Est. (USD)
9.13M / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.84M
8.29M
13.68M
9.13M
Cost of goods sold
2.01M
988.76K
2.24M
1.93M
Cost of revenue
2.01M
988.76K
2.24M
1.93M
Research and development expenses
1.47M
1.25M
1.55M
1.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.10M
7.01M
10.25M
7.62M
Operating expense
9.57M
9.27M
12.81M
10.33M
Total operating expenses
11.58M
10.26M
15.05M
12.26M
Operating income
-747.48K
-1.97M
-1.37M
-3.13M
Other non operating income
-
-
-
-
EBT including unusual items
-729.54K
-1.94M
-1.41M
-3.28M
EBT excluding unusual items
-729.54K
-1.94M
-1.41M
-3.14M
Income tax expense
5.67K
5.67K
23.24K
3.87K
Effective tax rate
-0.78%
-0.29%
-1.65%
-0.12%
Other operating expenses
-
-
-
-
Net income
-740.74K
-1.94M
-1.41M
-3.29M
Net profit margin
-6.83%
-23.40%
-10.32%
-36.03%
Earnings per share
-
-
-
-
Interest and investment income
127.49K
131.58K
91.97K
78.03K
Interest expense
-109.55K
-109.70K
-112.94K
-85.84K
Net interest expenses
17.94K
21.88K
-20.98K
-7.81K
Depreciation and amortization charges
-
-
-
-
EBITDA
286.44K
-927.46K
-329.31K
-1.85M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer